MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Versartis Company Profile (NASDAQ:VSAR)

Consensus Ratings for Versartis (NASDAQ:VSAR) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $18.50 (76.53% upside)

Analysts' Ratings History for Versartis (NASDAQ:VSAR)
Show:
DateFirmActionRatingPrice TargetActions
5/10/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016Morgan StanleyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2016Northland SecuritiesInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016Citigroup Inc.Lower Price Target$22.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2015Credit SuisseDowngradeNeutral -> Underperform$20.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2015SunTrustReiterated RatingBuy$50.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for Versartis (NASDAQ:VSAR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
2/18/2016Q415($0.71)($0.69)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q3($0.79)($0.69)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q2($0.64)($0.67)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015($0.70)($0.79)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2015Q414($0.53)($0.65)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q3 14($0.46)($0.57)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2014Q114($6.37)($2.57)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Versartis (NASDAQ:VSAR)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Versartis (NASDAQ:VSAR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Versartis (NASDAQ:VSAR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/15/2016Joshua T BrummCFOSell1,448$10.63$15,392.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2016Paul WestbergVPSell725$10.63$7,706.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Joshua T BrummCFOSell1,265$7.87$9,955.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/21/2016Paul WestbergVPSell1,430$9.68$13,842.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/30/2015Joshua T BrummCFOSell990$12.44$12,315.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/30/2015Paul WestbergVPSell362$12.44$4,503.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015Joshua T BrummCFOBuy2,500$9.99$24,975.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015R Scott GreerDirectorBuy10,000$10.17$101,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/6/2015Paul WestbergVPSell2,400$15.00$36,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2015Paul WestbergVPSell2,400$16.73$40,152.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2015Paul WestbergVPSell2,400$17.47$41,928.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2015Jeffrey L ClelandCEOSell8,000$20.13$161,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2015Paul WestbergVPSell2,400$17.49$41,976.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Jeffrey L ClelandCEOSell4,000$20.26$81,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2015Jeffrey L ClelandCEOSell3,179$20.03$63,675.37View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Jeffrey L ClelandCEOSell4,000$20.23$80,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Jeffrey L ClelandCEOSell2,871$20.11$57,735.81View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Paul WestbergVPSell5,000$17.40$87,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2015Aisling Capital Iii LpMajor ShareholderBuy145,000$17.25$2,501,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2015R Scott GreerDirectorBuy5,500$17.25$94,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2015Shahzad MalikDirectorBuy55,000$17.25$948,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Jeffrey L ClelandCEOSell4,000$22.85$91,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Jeffrey L ClelandCEOSell4,000$21.94$87,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Paul WestbergVPSell5,000$22.48$112,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/29/2014Jeffrey L ClelandCEOSell4,000$22.11$88,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2014Jeffrey L ClelandCEOSell8,000$21.14$169,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2014Leaf Ventures Ii L.P. NewMajor ShareholderSell150,000$19.01$2,851,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014Paul WestbergVPSell10,000$18.55$185,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2014Ventures Iv (Jersey) Lp IndexMajor ShareholderSell17,207$18.02$310,070.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/21/2014Ventures Iv (Jersey) Lp IndexMajor ShareholderSell26,793$18.04$483,345.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2014Ventures Iv (Jersey) Lp IndexMajor ShareholderSell9,000$18.32$164,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2014Ventures Iv (Jersey) Lp IndexMajor ShareholderSell191,362$19.38$3,708,595.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014Ventures Iv (Jersey) Lp IndexMajor ShareholderSell12,438$19.43$241,670.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014Ventures Iv (Jersey) Lp IndexMajor ShareholderSell36,200$19.42$703,004.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/29/2014Leaf Ventures Ii L.P. NewMajor ShareholderSell12,556$20.02$251,371.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/27/2014Leaf Ventures Ii L.P. NewDirectorBuy60,000$21.02$1,261,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/26/2014Aisling Capital Iii LpMajor ShareholderBuy60,000$21.00$1,260,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Versartis (NASDAQ:VSAR)
DateHeadline
06/14/16 05:37 AMLpath (LPTN), Arcadia (RKDA), Helios (HMNY) Post Biggest Moves today
06/03/16 05:09 AMVERSARTIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement -
06/02/16 12:03 PMVersartis, Inc. :VSAR-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016 -
05/25/16 01:47 PMVersartis Inc (VSAR) is Trading Higher on Unusual Volume for May 23 - Equities.com - Versartis Inc (VSAR) is Trading Higher on Unusual Volume for May 23Equities.comVersartis Inc (VSAR) experienced unusually high volume on May. 23, as the stock gained 8.38% to a closing price of $8.79. The stock saw 118,419 shares trade hands over the course of the day on 838 trades. Given that the stock's average daily volume ...
05/25/16 01:47 PMVersartis Inc (VSAR) Jumps 8.38% on May 23 - Equities.com - Versartis Inc (VSAR) Jumps 8.38% on May 23Equities.comVersartis Inc (VSAR) was among the biggest gainers on the Russell 2000 for Monday May 23 as the stock popped 8.38% to $8.79, representing a gain of $0.68 per share. Some 118,419 shares traded hands on 838 trades, compared with an average daily ...and more »
05/23/16 03:03 PMVERSARTIS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/19/16 01:32 PMVersartis Inc (VSAR) Jumps 5.89% on May 16 - Equities.com - Versartis Inc (VSAR) Jumps 5.89% on May 16Equities.comVersartis Inc (VSAR) was among the biggest gainers on the Russell 2000 for Monday May 16 as the stock popped 5.89% to $7.91, representing a gain of $0.44 per share. Some 43,774 shares traded hands on 489 trades, compared with an average daily ...and more »
05/11/16 07:30 AMVersartis Inc (VSAR) Jumps 5.69% on May 09 - Equities.com - Versartis Inc (VSAR) Jumps 5.69% on May 09Equities.comVersartis Inc (VSAR) was among the biggest gainers on the Russell 2000 for Monday May 09 as the stock popped 5.69% to $8.17, representing a gain of $0.44 per share. Some 74,956 shares traded hands on 697 trades, compared with an average daily ...and more »
05/11/16 07:30 AMVersartis Inc (VSAR) Receives “Buy” Rating from Canaccord Genuity - Washington News Wire - Washington News WireVersartis Inc (VSAR) Receives “Buy” Rating from Canaccord GenuityWashington News WireVersartis Inc (NASDAQ:VSAR)'s stock had its “buy” rating reaffirmed by equities research analysts at Canaccord Genuity in a research report issued to clients and investors on Tuesday, MarketBeat Ratings reports. Other equities analysts have also ...Versartis Inc (VSAR) Receives "Buy" Rating from Canaccord GenuityNewsWay 21Versartis' (VSAR) Buy Rating Reaffirmed at Canaccord GenuityWeb Breaking Newsall 3 news articles »
05/06/16 08:06 AMLatest Analyst Ratings For Versartis, Inc. (NASDAQ:VSAR) - Share Trading News - Latest Analyst Ratings For Versartis, Inc. (NASDAQ:VSAR)Share Trading NewsVersartis, Inc. has a 50 day moving average of 8.55 and a 200 day moving average of 9.83. The stock's market capitalization is 228.56M, it has a 52-week low of 6.17 and a 52-week high of 22.66. The share price of the company (NASDAQ:VSAR) was up ...
05/06/16 08:06 AMVersartis Inc (VSAR) Drops 6.37% on May 03 - Equities.com - Versartis Inc (VSAR) Drops 6.37% on May 03Equities.comVersartis Inc (VSAR) was one of the Russell 2000's biggest losers for Tuesday May 03 as the stock slid 6.37% to $8.52, a loss of $-0.58 per share. Starting at an opening price of $8.97 a share, the stock traded between $8.49 and $9.21 over the course ...and more »
05/06/16 08:06 AMVersartis Inc (VSAR) is Trading Lower on Unusual Volume for May 04 - Equities.com - Versartis Inc (VSAR) is Trading Lower on Unusual Volume for May 04Equities.comVersartis Inc (VSAR) experienced unusually high volume on May. 04, as the stock lost 13.03% to a closing price of $7.41. The stock saw 180,640 shares trade hands over the course of the day on 1,447 trades. Given that the stock's average daily volume ...What's Versartis Inc Upside After Today's Huge Increase?B.O.D.Y Confidentialall 2 news articles »
05/04/16 06:41 AMHow Analysts Feel About Versartis Inc (NASDAQ:VSAR)? - B.O.D.Y Confidential - How Analysts Feel About Versartis Inc (NASDAQ:VSAR)?B.O.D.Y ConfidentialOut of 6 analysts covering Versartis Inc (NASDAQ:VSAR), 4 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 67% are positive. Versartis Inc has been the topic of 6 analyst reports since August 13, 2015 according to StockzIntelligence Inc. Below is ...and more »
05/04/16 05:14 AMVERSARTIS, INC. Files SEC form 10-Q, Quarterly Report -
05/01/16 07:51 AMVersartis, Inc. (NASDAQ:VSAR) ABR of 1.67 - Investor Newswire - Versartis, Inc. (NASDAQ:VSAR) ABR of 1.67Investor NewswireAnalysts have a buy call on Versartis, Inc. (NASDAQ:VSAR) stock. As of 2016-04-29, the stock has an ABR of 1.67. This rating comes on a scale of 1-5, where one makes a strong buy call, and 3 indicates Strong Sell. This ABR computation is done on basis ...and more »
04/28/16 05:29 PMVersartis reports 1Q loss -
04/28/16 03:56 PM4:56 pm Versartis reports Q1 EPS of ($0.82) vs. ($0.77) Capital IQ consensus -
04/28/16 03:36 PMVersartis Reports First Quarter 2016 Financial Results - [at noodls] - MENLO PARK, Calif., April 28, 2016 (GLOBE NEWSWIRE) -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan (VRS-317), a novel, long-acting form ...
04/27/16 09:32 AMVersartis, Inc. (VSAR) Files Form 4 Insider Selling : Paul Westberg Sells 1430 Shares - Market Digest - Web Breaking NewsVersartis, Inc. (VSAR) Files Form 4 Insider Selling : Paul Westberg Sells 1430 SharesMarket DigestVersartis, Inc. (VSAR): Paul Westberg , Sr. VP, Business Development of Versartis, Inc. sold 1,430 shares on Apr 21, 2016. The Insider selling transaction was reported by the company on Apr 25, 2016 to the Securities and Exchange Commission. The shares ...Versartis Inc (NASDAQ:VSAR) Receives Average Recommendation of "Buy" from BrokeragesWeb Breaking NewsHow Many Versartis Inc (NASDAQ:VSAR)'s Analysts Are Bullish?CCH Daily Newsall 4 news articles »
04/27/16 09:32 AMVersartis, Inc. (NASDAQ:VSAR) Latest Broker Views - Risers & Fallers - Versartis, Inc. (NASDAQ:VSAR) Latest Broker ViewsRisers & FallersA number of investment brokers have recently updated their price targets on shares of Versartis, Inc. (NASDAQ:VSAR). According to the latest broker reports outstanding on Wednesday 27th of April, 0 analysts have a rating of “strong buy”, 0 analysts ...
04/23/16 08:26 AMRecently Changed Price Targets On Versartis, Inc. (NASDAQ:VSAR) - Risers & Fallers - Recently Changed Price Targets On Versartis, Inc. (NASDAQ:VSAR)Risers & FallersA number of investment brokers have recently updated their price targets on shares of Versartis, Inc. (NASDAQ:VSAR). Most recent broker ratings. 12/21/2015 – Citigroup began new coverage on Versartis, Inc. giving the company a “buy” rating. They now ...Zacks Investment Research Downgrades Versartis Inc (VSAR) to HoldWeb Breaking Newsall 2 news articles »
04/19/16 09:30 AMVersartis, Inc. (NASDAQ:VSAR) Has An Average Rating Of 3 - Investor Newswire - Versartis, Inc. (NASDAQ:VSAR) Has An Average Rating Of 3Investor NewswireAlpha One uses algorithm-based analytics to know about a stock sentiment varying as per the published content on online channels. In this analysis, the group considers only the most relevant news sources on a daily basis. Versartis, Inc. (NASDAQ:VSAR) ...and more »
04/15/16 12:01 PMUWM's Holdings Imply 12% Gain Potential - Three of UWM's underlying holdings with notable upside to their analyst target prices are Foamix Pharmaceuticals Ltd. (FOMX), Versartis Inc (VSAR), and Curis Inc (CRIS). Although FOMX has traded at a recent price of $6.84/share, the average analyst target ...
04/12/16 12:00 PMVersartis, Inc. (NASDAQ:VSAR) Broker Price Targets For The Coming Week - Share Trading News - Versartis, Inc. (NASDAQ:VSAR) Broker Price Targets For The Coming WeekShare Trading NewsRecently some investment brokers have made changes to their outstanding price targets on shares of Versartis, Inc. (NASDAQ:VSAR). According to data from Reuters, 3 analysts have a rating of “buy”, 1 analysts “outperform”, 1 analysts “hold”, 1 analysts ...Versartis Incorporated (NASDAQ:VSAR) Sellers Covered 2.54% of Their ShortsRiversideGazette.comall 2 news articles »
04/09/16 11:26 AMVersartis, Inc. (NASDAQ:VSAR) Updated Broker Price Targets - Share Trading News - Versartis, Inc. (NASDAQ:VSAR) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Versartis, Inc. (NASDAQ:VSAR). The latest reports which are currently in issue on Friday 8th of April state 2 analysts have a rating of “strong buy”, 1 analysts “buy”, 1 ...and more »
04/09/16 11:26 AMHow Analysts Rated Versartis Inc (NASDAQ:VSAR) Last Week? - RiversideGazette.com - The Vista VoiceHow Analysts Rated Versartis Inc (NASDAQ:VSAR) Last Week?RiversideGazette.comOut of 6 analysts covering Versartis Inc (NASDAQ:VSAR), 3 rate it “Buy”, 1 “Sell”, while 1 “Hold”. This means 60% are positive. Versartis Inc was the topic in 6 analyst reports since August 13, 2015 according to StockzIntelligence Inc. Below is a list ...Versartis Inc (VSAR) Coverage Initiated by Analysts at Northland SecuritiesThe Vista Voiceall 2 news articles »
04/08/16 12:10 PMCormorant Asset Management Exits Position in Versartis Inc (VSAR) - Street Edition - Cormorant Asset Management Exits Position in Versartis Inc (VSAR)Street EditionVersartis Inc (VSAR) : Cormorant Asset Management has sold out all of its stake in Versartis Inc during the Q4 period, according to the information disclosed to the SEC. The investment management company has sold out 170,000 shares of Versartis Inc ...Versartis, Inc. (NASDAQ:VSAR) Updated Analyst CoverageRisers & Fallersall 2 news articles »
04/08/16 12:10 PMVersartis Inc (VSAR) Jumps 11.44% on April 06 - Equities.com - Versartis Inc (VSAR) Jumps 11.44% on April 06Equities.comVersartis Inc (VSAR) was among the biggest gainers on the Russell 2000 for Wednesday April 06 as the stock popped 11.44% to $9.35, representing a gain of $0.96 per share. Some 246,399 shares traded hands on 1,947 trades, compared with an average ...and more »
04/07/16 12:31 PMVersartis, Inc. (NASDAQ:VSAR) Updated Analyst Coverage - Risers & Fallers - Versartis, Inc. (NASDAQ:VSAR) Updated Analyst CoverageRisers & FallersA number of investment brokers have recently updated their price targets on shares of Versartis, Inc. (NASDAQ:VSAR). According to the latest broker reports outstanding on Thursday 7th of April, 2 analysts have a rating of “strong buy”, 1 analysts “buy ...
04/06/16 02:08 PMVersartis Inc (VSAR) Earns “Buy” Rating from Canaccord Genuity - MicroCap Magazine - The Vista VoiceVersartis Inc (VSAR) Earns “Buy” Rating from Canaccord GenuityMicroCap MagazineVersartis Inc (NASDAQ:VSAR)'s stock had its “buy” rating reissued by Canaccord Genuity in a note issued to investors on Monday, AnalystRatings.NET reports. Several other equities analysts have also issued reports on the stock. Citigroup Inc. cut their ...Versartis' (VSAR) "Buy" Rating Reaffirmed at Canaccord GenuityThe Vista VoiceVersartis Incorporated (NASDAQ:VSAR) Shorted Shares Decreased By 2.54%RiversideGazette.comall 3 news articles »
04/05/16 01:34 PMVersartis Incorporated (NASDAQ:VSAR) Shorted Shares Decreased By 2.54% - RiversideGazette.com - The Vista VoiceVersartis Incorporated (NASDAQ:VSAR) Shorted Shares Decreased By 2.54%RiversideGazette.comThe short interest to Versartis Incorporated's float is 14.64%. The stock is up 4.22% or $0.35 after the news, hitting $8.52 per share. About 70,278 shares traded hands. Versartis Inc (NASDAQ:VSAR) has declined 37.87% since August 27, 2015 and is ...Versartis' (VSAR) "Buy" Rating Reaffirmed at Canaccord GenuityThe Vista Voiceall 2 news articles »
04/04/16 08:51 AMVersartis (VSAR) Shares March Higher, Can It Continue? -
04/04/16 07:36 AMVERSARTIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
04/03/16 01:20 PMPerceptive Advisors Lowers stake in Versartis Inc (VSAR) - Everything HUDSON - Perceptive Advisors Lowers stake in Versartis Inc (VSAR)Everything HUDSONVersartis Inc (VSAR) : Perceptive Advisors reduced its stake in Versartis Inc by 0.8% during the Q4 period. The investment management company now holds a total of 2,299,454 shares of Versartis Inc which is valued at $16 Million after selling 18,500 ...Versartis Inc was rated by Empire Asset Management to TerminatesThe Duncan Independent (press release) (blog)all 2 news articles »
04/01/16 01:57 PMVersartis Inc (VSAR) Jumps 14.92% on March 29 - Equities.com - Versartis Inc (VSAR) Jumps 14.92% on March 29Equities.comVersartis Inc (VSAR) was among the biggest gainers on the Russell 2000 for Tuesday March 29 as the stock popped 14.92% to $7.55, representing a gain of $0.98 per share. Some 161,231 shares traded hands on 1,340 trades, compared with an average ...and more »
04/01/16 06:13 AMVersartis Presents Confirmatory 18-Month Adherence Data from Ongoing Somavaratan Extension Study at Late-Breaker Session at ENDO Annual Meeting - [at noodls] - MENLO PARK, Calif., April 01, 2016 (GLOBE NEWSWIRE) -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan (VRS-317), a novel, long-acting form ...
04/01/16 06:06 AMVERSARTIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits -
03/30/16 07:41 AMVersartis Appoints Colin Hislop, M.D., as Chief Medical Officer - [at noodls] - MENLO PARK, Calif., March 30, 2016 (GLOBE NEWSWIRE) -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan (VRS-317), a novel, long-acting form ...
03/26/16 01:17 PMVersartis Incorporated (NASDAQ:VSAR) Short Interest Increased By 1.31% - RiversideGazette.com - Versartis Incorporated (NASDAQ:VSAR) Short Interest Increased By 1.31%RiversideGazette.comThe short interest to Versartis Incorporated's float is 15.02%. The stock increased 3.23% or $0.21 on March 24, hitting $6.71. About 48,292 shares traded hands. Versartis Inc (NASDAQ:VSAR) has declined 53.27% since August 19, 2015 and is downtrending.
03/25/16 01:57 PMPrice Target Update On Versartis, Inc. (NASDAQ:VSAR) - Risers & Fallers - Price Target Update On Versartis, Inc. (NASDAQ:VSAR)Risers & FallersA number of investment brokers have recently updated their price targets on shares of Versartis, Inc. (NASDAQ:VSAR). According to the latest broker reports 2 analysts have a rating of “buy”, 1 analysts “outperform”, 1 analysts “hold”, 1 analysts ...Versartis Inc Has Another Very Weak Trading SessionBusiness Standard Tribuneall 2 news articles »
03/25/16 01:57 PMWere Analysts Bearish Versartis Inc (NASDAQ:VSAR) This Week? - RiversideGazette.com - Were Analysts Bearish Versartis Inc (NASDAQ:VSAR) This Week?RiversideGazette.comOut of 5 analysts covering Versartis Inc (NASDAQ:VSAR), 3 rate it “Buy”, 1 “Sell”, while 1 “Hold”. This means 60% are positive. Versartis Inc was the topic in 5 analyst reports since August 13, 2015 according to StockzIntelligence Inc. Below is a list ...
03/25/16 01:57 PMVersartis Inc (VSAR) Drops 7.8% on March 23 - Equities.com - Versartis Inc (VSAR) Drops 7.8% on March 23Equities.comVersartis Inc (VSAR) was one of the Russell 2000's biggest losers for Wednesday March 23 as the stock slid 7.8% to $6.50, a loss of $-0.55 per share. Starting at an opening price of $7.05 a share, the stock traded between $6.44 and $7.11 over the ...and more »
03/19/16 11:41 AMWhat Will Happen to Versartis Inc Next? The Stock Just Increased A Lot - Business Standard Tribune - What Will Happen to Versartis Inc Next? The Stock Just Increased A LotBusiness Standard TribuneThe stock of Versartis Inc (NASDAQ:VSAR) is a huge mover today! The stock increased 5.30% or $0.35 during the last trading session, hitting $6.96. About 203,431 shares traded hands or 18.63% up from the average. Versartis Inc (NASDAQ:VSAR) has ...
03/18/16 01:15 PMVersartis, Inc. (NASDAQ:VSAR) Broker Views - Risers & Fallers - Versartis, Inc. (NASDAQ:VSAR) Broker ViewsRisers & FallersA number of investment brokers have recently updated their price targets on shares of Versartis, Inc. (NASDAQ:VSAR). According to the latest broker reports outstanding on Friday 18th of March, 2 analysts have a rating of “strong buy”, 1 analysts “buy”, ...
03/17/16 12:59 PMVersartis Inc (VSAR) Drops 7.09% on March 15 - Equities.com - Versartis Inc (VSAR) Drops 7.09% on March 15Equities.comVersartis Inc (VSAR) was one of the Russell 2000's biggest losers for Tuesday March 15 as the stock slid 7.09% to $6.42, a loss of $-0.49 per share. Starting at an opening price of $6.78 a share, the stock traded between $6.40 and $6.81 over the course ...and more »
03/15/16 11:07 AMVersartis Announces Two Abstracts from Ongoing Pediatric Extension Study of Somavaratan Selected for Late-Breaker Presentations at the Endocrine… - MENLO PARK, Calif., March 14, 2016 (GLOBE NEWSWIRE) — Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan (VRS-317), a novel, long-acting form of recombinant human growth hormone (rhGH) for growth ...
03/15/16 11:07 AMVersartis (VSAR) Says Two Abstracts from Pediatric Extension Study of Somavaratan Selected for Late-Breaker Presentations at ENDO - Versartis, Inc. (NASDAQ: VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan (VRS-317), a novel, long-acting form of recombinant human growth hormone (rhGH) for growth hormone deficiency (GHD), today announced that detailed ...
03/14/16 12:40 PMVersartis Announces Two Abstracts from Ongoing Pediatric Extension Study of Somavaratan Selected for Late-Breaker Presentations at the Endocrine Society’s 98th Annual Meeting - [GlobeNewswire] - MENLO PARK, Calif., March 14, 2016-- Versartis, Inc., an endocrine-focused biopharmaceutical company that is developing somavaratan, a novel, long-acting form of recombinant human growth hormone for growth ...
03/11/16 12:04 PMVERSARTIS, INC. Financials -
03/09/16 01:52 PMVersartis Inc (VSAR) Drops 10.76% on March 08 - Equities.com - Versartis Inc (VSAR) Drops 10.76% on March 08Equities.comVersartis Inc (VSAR) was one of the Russell 2000's biggest losers for Tuesday March 08 as the stock slid 10.76% to $6.97, a loss of $-0.84 per share. Starting at an opening price of $7.74 a share, the stock traded between $6.95 and $7.92 over the ...and more »
About Versartis

Versartis logoVersartis, Inc. is an endocrine-focused biopharmaceutical company. The Company is engaged in developing long-acting recombinant human growth hormone (rhGH), somavaratan (VRS-317), for growth hormone deficiency (GHD), an orphan disease. The Company's product pipeline includes VRS-317 and XTEN Technology. The Company's VRS-317 combines the rhGH amino acid sequence utilized in approved rhGH products with a half-life extension technology, XTEN, to enable less frequent administration. The XTEN technology consists of hydrophilic amino acids added at the genetic level as part of the manufacturing process. The Company's XTEN is a recombinant polypeptide designed to extend the in vivo half-life of peptides and proteins in a tunable manner. The XTEN sequence consists of hydrophilic amino acids and possesses various additional properties, which are used for the development of protein pharmaceuticals.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: VSAR
  • CUSIP:
Key Metrics:
  • Previous Close: $11.54
  • 50 Day Moving Average: $9.56
  • 200 Day Moving Average: $9.45
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $308.41M
  • Current Quarter EPS Consensus Estimate: $-3.29 EPS
Additional Links:
Versartis (NASDAQ:VSAR) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha